SCHEMBL5897692

SCHEMBL5897692

Cc1ccc(NC(=O)c2ccc(C#N)cc2)cc1NC(=O)c1ccc2ncccc2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 4/20 0.67
HSF1 Q00613 2/20 0.67
CSF1R P07333 1/20 0.64
NPC1 O15118 4/20 0.61
RAB9A P51151 4/20 0.61
POLB P06746 1/20 0.61
PABPC1 P11940 1/20 0.56
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
HDAC1 Q13547 1/20 0.52
HDAC2 Q92769 1/20 0.52
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
SENP6 Q9GZR1 1/20 0.51
BLK P51451 1/20 0.50
BTK Q06187 1/20 0.50
PLK1 P53350 1/20 0.50
PIR O00625 1/20 0.49
MMP9 P14780 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5897251 0.89 BRAF (0.76) BRAFHSF1CSF1RNPC1RAB9A
SCHEMBL5897360 0.88 PABPC1 (0.56) BRAFHSF1CSF1RNPC1RAB9A
SCHEMBL6975716 0.88 BRAF (0.72) BRAFHSF1CSF1RNPC1RAB9A
SCHEMBL5897048 0.87 BRAF (0.71) BRAFHSF1CSF1RNPC1RAB9A
SCHEMBL5897226 0.85 BRAF (0.87) BRAFHSF1CSF1RNPC1RAB9A
SCHEMBL6979265 0.85 BRAF (0.77) BRAFHSF1CSF1RNPC1RAB9A
SCHEMBL5897118 0.84 BRAF (0.69) BRAFHSF1CSF1RNPC1RAB9A
SCHEMBL5897487 0.82 CSF1R (0.81) BRAFHSF1CSF1RNPC1RAB9A
SCHEMBL5896793 0.82 BRAF (0.67) BRAFHSF1CSF1RNPC1RAB9A
SCHEMBL6977566 0.82 BRAF (0.62) BRAFHSF1CSF1RNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7060700-B2 Amide derivatives useful as inhibitors of the production of cytokines ASTRAZENECA AB (SE) 2006-06-13 US disclosed
US-20030105142-A1 Amide derivatives useful as inhibitors of the production of cytokines ASTRAZENECA AB 2003-06-05 US disclosed
US-6432949-B1 Amide derivatives useful as inhibitors of the production of cytokines ASTRAZENECA AB (SE) 2002-08-13 US disclosed
EP-1102750-A1 AMIDE DERIVATIVES USEFUL AS INHIBITORS OF THE PRODUCTION OF CYTOKINES AstraZeneca AB (SE) 2001-05-30 EP disclosed
WO-2000007991-A1 AMIDE DERIVATIVES USEFUL AS INHIBITORS OF THE PRODUCTION OF CYTOKINES ASTRAZENECA AB (SE) 2000-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105142-A1 Amide derivatives useful as inhibitors of the production of cytokines IL6, IL6ST, IL2 BRAF 1764/4885HSF1 2604/4885CSF1R 273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.